Stamford Therapeutics Consortium

Diabetes (Type 2)

Type 2 diabetes, formerly called non-insulin-dependent diabetes, or adult-onset diabetes, occurs when the body’s cells are resistant to insulin. The pancreas may initially produce enough insulin, but the body cannot utilize it properly as fuel. After several years though, insulin production may slow down in the body. Type 2 diabetes is also characterized by high blood glucose, but if blood sugar levels are properly maintained, then the risk of complications such as neuropathy and blindness can be reduced. Although the disease is often viewed as a progressive one, it is because of poor management. Although it is a chronic disease, there are treatments that can effectively delay or prevent consequences of the disease.

Type 2 diabetes is associated with aging, although an increasing number of children are being diagnosed due to increasing obesity rates. Other factors include family history of diabetes, pervious history of gestational diabetes, physical inactivity, ethnicity and obesity. 90 to 95 percent of diabetics suffer from type 2.

Possible symptoms of type 2 diabetes may include:

• Nausea
• Frequent Urination
• Unusual Thirst
• Increased Fluid Intake
• Weight Loss
• Blurred Vision
• Frequent Infections
• Slow Healing
• Lethargy
• Fatigue
• Changes in Metabolism


Sorry, we are currently not conducting a clinical trial for this condition. Please check back because we frequently add new studies. Feel free to contact Judy Dalgin, our Site Manager, for more information about upcoming trials.

Clinical Trial Contact FormYou may also fill out the Clinical Trial Contact Form and we will contact you when a new trial is added for any of the conditions you have indicated.

Judy Dalgin (Site Manager)
email: jdalgin@stctrials.com
telephone: 203-325-8529

Stamford Therapeutics Consortium

Copyright © • Stamford Therapeutics Consortium • All Rights Reserved
Website Designed & Maintained By SkyeLine Studio, LLC.